Mammalian target of rapamycin and head and neck squamous cell carcinoma

Yu Min Liao, Charles Kim, Yun Yen

Research output: Contribution to journalReview articlepeer-review

28 Citations (Scopus)


Head and neck squamous cell carcinoma (HNSCC), a significant cause of cancer deaths worldwide, has multiple stepwise malignant evolutions. Mammalian target of rapamycin (mTOR) plays a critical role in tumor development, invasion, metastasis and angiogenesis that impact local recurrence and survival. mTOR can also act as a biomarker for personalized adjuvant therapy. In in vivo and in vitro studies, mTOR inhibitor suppresses tumor growth and sensitizes HNSCC to radiation, cytotoxic agents and epidermoid growth factor receptor inhibitors. We have reviewed the pathogenesis of HNSCC, mTOR pathway, mTOR inhibitor and the role of mTOR in HNSCC.

Original languageEnglish
Article number22
JournalHead and Neck Oncology
Issue number1
Publication statusPublished - 2011

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Oncology


Dive into the research topics of 'Mammalian target of rapamycin and head and neck squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this